SHR-8068 Injection: Clinical Trials

5 trials of SHR-8068 Injection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 1 active not recruiting, 1 not yet recruiting. 4 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Recruiting 2, Active not recruiting 1, Not yet recruiting 1
Phase 11Recruiting 1
Phase 31Recruiting 1

Follow SHR-8068 Injection: new trials by email Literature Review of SHR-8068 Injection trials Research Report on SHR-8068 Injection

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Trial of SHR-8068 Combined With Adebrelimab and Apatinib in Perioperative Treatment of Resectable Hepatocellular Carcinoma
SHR-8068 Injection, Adebrelimab Injection, Apatinib Mesylate Tablets - Resectable Hepatocellular Carcinoma With Intermediate or High Recurrence Risk
Phase 2Not yet recruitingSuzhou Suncadia Biopharmaceuticals Co., Ltd.1202026-07-012026-07-02
A Phase III Study of SHR-8068 in Combination With Adebrelimab and Platinum-Containing Chemotherapy Versus Durvalumab in Combination With Platinum-Containing Chemotherapy as First-line Treatment for Advanced Biliary Tract Cancer (BTC)
SHR-8068 Injection, Adebrelimab Injection, Gemcitabine Hydrochloride for Injection - Advanced Biliary Tract Cancer
Phase 3RecruitingSuzhou Suncadia Biopharmaceuticals Co., Ltd.6042026-01-212026-01-28
A Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as Treatment for Gastric/GEJ Cancer
Adebrelimab Injection, SHR-A1811 for Injection, SHR-A1904 for Injection - Gastric Cancer, Gastroesophageal-junction Cancer
Phase 2RecruitingSuzhou Suncadia Biopharmaceuticals Co., Ltd.2002025-08-282026-01-09
A Phase II Study of SHR-8068 Injection in Combination With Anti-tumor Therapies in Colorectal Cancer
SHR-8068 Injection, Adebrelimab Injection, Bevacizumab Injection - Colorectal Cancer
Phase 2Active not recruitingSuzhou Suncadia Biopharmaceuticals Co., Ltd.1032025-07-222026-08-11
A Trial of SHR-A2102 With Antitumor Therapy in Advanced Urothelial Carcinoma
SHR-A2102, Adebrelimab injection, SHR-8068 injection - Advanced Urothelial Carcinoma
Phase 1 / Phase 2RecruitingShanghai Hengrui Pharmaceutical Co., Ltd.902024-11-042024-11-18

Conditions studied

Colorectal Neoplasms (1)  ·  Stomach Neoplasms (1)

Sponsors

Suzhou Suncadia Biopharmaceuticals Co., Ltd. (4)  ·  Shanghai Hengrui Pharmaceutical Co., Ltd. (1)

Countries

China (5)